Bibby Scientific Ltd Acquires PCRmax Ltd
News Sep 24, 2014
Bibby Scientific has purchased 100% of the share capital of PCRmax. They are also the registered owners of the intellectual property previously owned by Illimina Inc with respect to the ECO QPCR instrument.
PCRmax will launch the innovative ECO 48 well QPCR platform which has market leading uniformity and ramp rates allowing a real time experiment to be completed in as little as 8 minutes. A wide range of QPCR research kits and consumables will further enhance the product offering at launch. Over the next 12 months a further 3 instruments in the PCR and QPCR range plus supporting life science products will be added to this innovative offering.
Commenting on the acquisition, Dr James Heffernan, CEO of Bibby said "This acquisition underlines our determination to become a leading global player in the life science equipment arena through the offer of technologically leading products at prices affordable by scientists worldwide. The addition of a comprehensive range of quality research kits for use on the new platforms should prove a compelling offering to our customers".
Controlling mosquito-borne illnesses has historically been difficult. Scientists have turned to manipulating Wolbachia, a parasitic bacterium within mosquitoes, as a way to control the reproductive fitness of mosquito populations that transmit human disease. In a study, researchers identified a new mobile DNA element in Wolbachia, which may contribute to improved control strategies for mosquito vectors of disease.